The degeneration of dopamine neurons in Parkinson's disease: Insights from embryology and evolution of the mesostriatocortical system

Annals of the New York Academy of Sciences

Volumn 1035, Issue , 2004, Pages 231-249

  Vernier, Philippe ^a   Moret, Frederic ^a   Callier, Sophie ^a   Snapyan, Marina ^a   Wersinger, Christophe ^b   Sidhu, Anita ^b  

^a CNRS   (France)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Development; Dopamine receptors; Dopamine transporter; Neuroprotection; Parkinson's disease (PD); synuclein

Indexed keywords

ALPHA SYNUCLEIN; AMINE OXIDASE (FLAVIN CONTAINING); AROMATIC LEVO AMINO ACID DECARBOXYLASE; DOPAMINE; DOPAMINE TRANSPORTER; MICROTUBULE ASSOCIATED PROTEIN; NEUROTOXIN; PARKIN; TYROSINE 3 MONOOXYGENASE; VESICULAR MONOAMINE TRANSPORTER;

CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; DOPAMINE UPTAKE; DOPAMINERGIC NERVE CELL; EMBRYOLOGY; EVOLUTION; HEREDITY; HUMAN; MESENCEPHALON; MESOSTRIATOCORTICAL SYSTEM; NERVE CELL DIFFERENTIATION; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOPHYSIOLOGY; PHENOTYPE; VERTEBRATE;

VERTEBRATA;

EID: 14944342522     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1332.015     Document Type: Conference Paper

References (58)

1. FEARNLEY, J.M. & A. LEES. 1991. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 114: 2283-2301.
2. COTZIAS, G.C., M.H. VAN WOERT & L.M. SCHIFFER. 1967. Aromatic amino acids and modification of parkinsonism. N. Engl. J. Med. 276: 374-379.
3. PRZEDBORSKI, S., V. KOSTIC, N. GILADI, et al. 2003. Dopaminergic systems in Parkinson's disease, in dopamine receptors and transporters. A. Sidhu, M. Laruelle & P. Vernier, Eds.: 363-402. Marcel Dekker. New York.
4. DAUER, W. & S. PRZEDBORSKI. 2003. Parkinson's disease: mechanisms and models. Neuron 39: 889-909.
5. WICK, G., P. BERGER, P. JANSEN-DURR, et al. 2003. A Darwinian- evolutionary concept of age-related diseases. Exp. Gerontol. 38: 13-25.
6. ROSE, M., L. MUELLER & A. LONG. 2002. Pharmacology, genomics, and the evolutionary biology of ageing. Free Radical Res. 36: 1293-1297.
7. STEARNS, S. & D. EBERT. 2001. Evolution in health and disease: work in progress. Q. Rev. Biol. 76: 417-432.
8. EHRINGER, H. & O. HORNYKIEWICZ. 1960. Verteilung von noradrenalin und dopamine 3-hydroxy-tyramin in Gehirn des Menschen und ihr Verhalten by Erkrankungen des Extrapyramidalen systems. Klin. Wschr. 38: 1236-1239.
9. FOIX, M. 1921. Les lésions anatomiques de la Maladie de Parkinson. Rev. Neurol. 28: 593-600.
10. SAMII, A., J.G. NUTT & B.R. RANSOM. 2004. Parkinson's disease. Lancet 363: 1783-1793.
11. BRAAK, H., K. DEL TREDICI, U. RUB, et al. 2003. Staging of brain pathology associated to sporadic Parkinson's disease. Neurobiol. Aging 24: 197-211.
12. HIRSCH, B.C., G. HOGLINGER, E. ROUSSELET, et al. 2003 Animal models of Parkinson's disease in rodents induced by toxins: an update. J. Neural Trans, suppl. 65: 89-100.
13. DAWSON, T.M., & V.L. DAWSON. 2003 Molecular pathways of neurodegeneration in Parkinson's disease. Science 302: 819-822.
14. SIDHU, A., C. WERSINGER & P. VERNIER. 2004 Does α-synuclein modulate dopaminergic synaptic content and tone at the synapse? FASEB J. 18: 637-647.
15. GIASSON, B.I. & V.M. LEE. 2003. Are ubiquitination pathways central to Parkinson's disease? Cell 114: 1-8.
16. BABA, M., S. NAKAJO, P.H. TU, et al. 1998. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am. J. Pathol. 152: 879-884.
17. CONWAY, K.A., J.C. ROCHET, R.M. BIEGANSKI, et al. 2001. Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct. Science 294: 1346-1349.
18. SIDHU, A., C. WERSINGER & P. VERNIER. 2004 Alpha-synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease. FEBS Lett. 265: 1-5.
19. PEREZ, R.G., J.C. WAYMIRE, E. LIN, et al. 2002. A role for alpha-synuclein in the regulation of dopamine biosynthesis. J. Neurosci. 22: 3090-3099.
20. LOTHARIUS, J., S. BARG, P. WIEKOP, et al. 2002 Effect of mutant alpha-synuclein on dopamine homeostasis in a new human mesencephalic cell line. J. Biol. Hematol. 277: 38884-38894.
21. LOTHARIUS, J. & P. BRUNDIN. 2002. Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein. Nat. Rev. Neurosci. 3: 932-942.
22. WERSINGER, C., D. PROU, P. VERNIER, et al. 2003. Mutations in the lipid-binding domain of alpha-synuclein confer overlapping, yet distinct, functional properties in the regulation of dopamine transporter activity. Mol. Cell Neurosci. 24: 91-105.
23. EL-AGNAF, O.M. & G.B. IRVINE. 2002 Aggregation and neurotoxicity of alpha-synuclein and related peptides. Biochem. Soc. Trans. 30: 559-565.
24. LUCKING, C.B. & A. BRICE. 2000 Alpha-synuclein and Parkinson's disease. Cell. Mol. Life Sci. 57: 1894-1908.
25. HÖKFELT, T., R. MARTENSSON, A. BJÖRKLUND, el al. 1984 Distributional maps of tyrosine hydroxylase-immunoreactive neurons in the rat brain. In Handbook of Chemical Neuroanatomy. T. Hökfelt, Ed.: 277-386. Elsevier. Amsterdam.
26. PUELLES, L. & J.L. RUBENSTEIN. 1993. Expression patterns of homeobox and other putative regulatory genes in the embryonic mouse forebrain suggest a neuromeric organization. Trends Neurosci. 16: 472-479.
27. PUELLES, L. & J. RUBENSTEIN. 2003. Forebrain gene expression domains and the evolving prosomeric model. Trends Neurosci. 26: 469-476.
28. WULLIMANN, M.L. & L. PUELLES. 1999 Postembryonic neural proliferation in the zebrafish forebrain and its relationships to prosomeric domains. Anat. Embryol. 201: 329-348.
29. SMEETS, W.J. & A. REINER. 1994. Phylogeny and development of catecholamine systems in the CNS of vertebrates. Cambridge University Press. London.
30. SMEETS, W.J. & A. GONZALEZ. 2000. Catecholamine systems in the brain of vertebrates: new perspectives through a comparative approach. Brain Res. Rev. 33: 308-379.
31. KAPSIMALI, M., F. BOURRAT & P. VERNIER. 2001 Distribution of the orphan nuclear receptor nurr1 in medaka Oryzias latipes: cues to the definition of homologous territories in the vertebrate brain. J. Comp. Neurol. 431: 276-292.
32. RINK, E. & M.L. WULLIMANN. 2002. Connections of the ventral telencephalon and tyrosine hydroxylase distribution in the zebrafish brain Danio rerio lead to identification of an ascending dopaminergic system in a teleost. Brain Res. Bull. 57: 385-387.
33. PUELLES, L. & C. VERNEY. 1998. Early neuromeric distribution of tyrosine-hydroxylase-immunoreactive neurons in human embryos. J. Comp. Neurol. 394: 283-308.
34. PRENSA, L. & A. PARENT. 2001 The nigrostriatal pathway in the rat: a single-axon study of the relationship between dorsal and ventral tier nigral neurons and the striosome/matrix striatal compartments. J. Neurosci. 21: 7247-7260.
35. CERRUTI, C., D. WALTHER, M. KUHAR, et al. 1993. Dopamine transporter mRNA expression is intense in rat midbrain neurons and modest outside midbrain. Brain Res. Mol. Brain Res. 18: 181-186.
36. CILIAX, B.J., C. HEILMAN, L.L. DEMCHYSHYN, et al. 1995 The dopamine transporter: immunochemical characterization and localization in brain. J. Neurosci. 15: 1714-1723.
37. MEISTER, B. & R. ELDE. 1993. Dopamine transporter mRNA in neurons of the rat hypothalamus. Neuroendocrinology 58: 388-395.
38. CILIAX, B.J., G.W. DRASH, J.K. STALEY, et al. 1999. Immunocytochemical localization of the dopamine transporter in human brain. J. Comp. Neurol. 409: 38-56.
39. WEIHE, E. & L. EIDEN. 2000. Chemical neuroanatomy of the vesicular amine transporters. FASEB J. 14: 2435-2449.
40. LIN, J.C. & A. ROSENTHAL. 2003. Molecular mechanisms controlling the development of dopaminergic neurons. Cell Dev. Biol. 14: 175-180.
41. RIDDLE, R. & J. POLLOCK. 2003. Making connections: the development of mesencephalic dopaminergic neurons. Brain Res. Dev. Brain Res. 147: 3-21.
42. SMIDT, M., S. SMITS & J. BURBACH. 2003. Molecular mechanisms underlying midbrain dopamine neuron development and function. Eur. J. Pharmacol. 480: 75-88.
43. HYNES, M., J.A. PORTER, C. CHIANG, et al. 1995 Induction of midbrain dopaminergic neurons by Sonic hedgehog. Neuron 15: 35-44.
44. KIM, J., J. AUERBACH, J. RODRIGUEZ-GOMEZ, et al. 2002 Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 418: 50-56.
45. WURST, W. & L. BALLY-CUIF. 2001 Neural plate patterning: upstream and downstream of the isthmic organizer. Nat. Rev. Neurosci 2: 99-108.
46. ANDREWS, G., K. YUN, J.L. RUBENSTEIN, et al. 2003. Dix transcription factors regulate differentiation of dopaminergic neurons of the ventral thalamus. Mol. Cell Neurosci. 23: 107-120.
47. RINK, E. & M. WULLIMANN. 2002. Development of the catecholaminergic system in the early zebrafish brain: an immunohistochemical study. Brain Res. Dev. Brain Res. 137: 89-100.
48. VERNEY, C. & L. PUELLES. 2001. Structures of longitudinal brain zones that originate the substantia nigra and ventral tegmental area in human embryos, as revealed by cytoarchitecture, and tyrosine hydroxylase, calbindin, calretinin and GABA immunoreaction. J. Comp. Neurol. 429: 22-44.
49. HOLZSCHUH, J., G. HAUPTMANN & W. DRIEVER. 2003. Genetic analysis of the roles of Hh, FGF8, and nodal signaling during catecholaminergic system development in the zebrafish brain. J. Neurosci. 23: 5507-5519.
50. ZETTERSTROM, R.H., L. SOLOMIN, L. JANSSON, et al. 1997. Dopamine neuron agenesis in Nurr1-deficient mice. Science 276: 248-250.
51. JOSEPH, B., A. WALLEN-MACKENZIE, G. BENOIT, et al. 2003. p57Kip2 cooperates with Nurr1 in developing dopamine cells. Proc. Natl. Acad. Sci. USA 100: 15619-15624.
52. ABELIOVICH, A., Y. SCHMITZ, I. FARINAS, et al. 2000. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25: 239-252.
53. SIMON, H., H. SAUERESSIG, W. WURST, et al. 2001. Fate of midbrain dopamine neurons controlled by the Engrailed genes. J. Neurosci. 21: 3126-3134.
54. VALDENAIRE, O., P. VERNIER, M. MAUS, et al. 1994. Transcription of the rat dopamine-D2-receptor gene from two promoters. Eur. J. Biochem. 220: 577-584.
55. KAWASAKI, H., H. SUEMORI, K. MIZUSEKI, et al. 2002. Generation of dopaminergic neurons and pigmented epithelia from primate ES cells by stromal cell-derived inducing activity. Proc. Natl. Acad. Sci. USA 99: 1580-1585.
56. MOORE, M.W., R.D. KLEIN, I. FARINAS, et al. 1996. Renal and neural abnormalities in mice lacking GDNF. Nature 382: 76-79.
57. CASTELO-BRANCO, G., J. WAGNER, F. RODRIGUEZ, et al. 2003. Differential regulation of midbrain dopaminergic neuron development by Wnt-1, Wnt-3a, and Wnt-5a. Proc. Natl. Acad. Sci. USA 100: 12747-12752.
58. DAMIER, P., E. HIRSCH, Y. AGID, et al. 1999. The substantia nigra of the human brain. II. Patterns of loss of loss of dopamine-containing neurons. I. Parkinson's disease. Brain 122: 1437-1448.